Close Menu

data warehouse

Horizons Ventures led the round, joined by Airbus Ventures, bringing the MIT spinout's fundraising total to date to more than $21 million.

The charity also announced a partnership with Sage Bionetworks to establish an online repository for biomarker data generated by grant recipients.

Genomics England has slashed storage costs by migrating to a new file system, while NIH's All of Us research program is seeking savings from a cloud environment.

The offering of common stock will be the second for Twist this year and the third since the company made its initial public offering in October 2018.

Illumina, Twist Bioscience, and DNA Script are among the private sector collaborators of the groups receiving funds to develop technology platforms.

French biopreservation firm Imagene will provide Twist with DNAshell technology and services to advance the storage of digital data in DNA.

This new VC round brings the cancer informatics and precision medicine company's total fundraising to $520 million and its valuation to $3.1 billion.

The informatics firms signed agreements to offer certain of their genomic data technologies on Google's cloud-based computing services platform.

An affiliation with City of Hope, the advent of Illumina NovaSeq, and the availability of HPC flash storage have changed the nature of high-performance computing at TGen.

Following the launch of GenoVic last year, the organization is working to get more centers on the platform and figure out its role in an A$500M national initiative.

Pages

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.